Mixed AIM disclosures demand different tests across Cora Gold, Petards, Tap Global and SkinBioTherapeutics

Mixed AIM disclosures demand different tests across Cora Gold, Petards, Tap Global and SkinBioTherapeutics →

Highlights The same-day AIM slate spans exploration evidence, specialist orders, corporate governance and health-related commercial development. Petards has explicitly indicated that recent rail orders are not material to group expectations…